What is aTyr Pharma's market cap?

aTyr Pharma (ATYR) has a market capitalization of $51.9M and trades on NASDAQ.

Who are aTyr Pharma's competitors?

aTyr Pharma's key competitors include Bristol Myers Squibb Company, Merck & Co., United Therapeutics, and others. These companies compete in similar markets and product categories.

Who does aTyr Pharma partner with?

aTyr Pharma's notable partners include Kyorin Pharmaceutical Co., Ltd., The Ohio State University.

What subsidiaries does aTyr Pharma have?

aTyr Pharma's subsidiaries include Pangu BioPharma.

Where is aTyr Pharma headquartered?

aTyr Pharma is headquartered in United States of America and employs approximately 59 people. It has been publicly traded since 2015.

aTyr Pharma (ATYR) Stock Fundamentals & Financials

Ethos Technologies Inc. (operating as aTyr Pharma) is a clinical-stage biotechnology company focused on developing first-in-class biologics derived from tRNA synthetase biology.

Market cap

$51.88M-89.7%

Net income-$60.8M+8.8%

Free cash flow-$54.8M+1.5%

EPS (diluted)-$0.62+21.5%

Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

August 7, 2026

Revenue$189.6M EPS-$0.11Beat by $0.01

Read the full report

Next report

Nov 5, 2026 (in 3 months)

Revenue estimate$2.5M

EPS estimate-$0.17

Financials

Q2 2026

Income statement

See full

Operating income-$10.9M+46.4%

Net income-$10.3M+47.2%

EPS (diluted)-$0.11+50.0%

Balance sheet

See full

Cash & equivalents$16.2M-6.2%

Total debt$11.8M-10.7%

Total equity$48.8M-34.8%

Total assets$69.8M-31.2%

Cash flow

See full

Operating cash flow-$9.4M+32.7%

CapEx$73.0K+711%

Free cash flow-$9.4M+32.2%

Valuation & ratios

Valuation

See full

Market cap$50.14M-89.7%

Enterprise value$45.8M-90.4%

Returns & leverage

See full

Return on equity-98.4%+18.0pp

Debt / equity0.2×+0.1×

Current ratio5.1×-0.5×

Competitors

By market cap

Merck & Co.$317.57B+57.6%

Bristol-Myers Squibb$132.20B+41.4%

United Therapeutics$23.1B+69.5%

Rein Therapeutics Inc.$69.9M+173%

Instil Bio$50.3M-72.6%

aTyr Pharma$50.1M-89.4%

Werewolf Therapeutics, Inc.$19.3M-63.2%

TransCode Therapeutics, Inc.$4.2M-51.6%

By revenue growth

Merck & Co.+4.6%

Bristol-Myers Squibb+3.1%

United Therapeutics+2.5%

By net margin

United Therapeutics41.56%+1.2pp

Bristol-Myers Squibb18.87%+8.4pp

Merck & Co.4.77%-21.0pp

aTyr Pharma-39,009.47%—

Profile

Ethos Technologies Inc. (operating as aTyr Pharma) is a clinical-stage biotechnology company focused on developing first-in-class biologics derived from tRNA synthetase biology. The company leverages its proprietary evolutionary intelligence platform to identify novel protein domains that regulate immune and fibrotic pathways, aiming to treat severe inflammatory and fibrotic diseases.

Competitive position

A pioneer in tRNA synthetase biology with a leading clinical candidate for pulmonary sarcoidosis and established strategic partnerships in Asian markets.

GeographiesUnited States, Japan, Europe, Brazil

Customer segmentsPharmaceutical companies, Patients with rare diseases

Business modelR&D intensive, Licensing and Royalties, B2B

SuppliersContract Development and Manufacturing Organizations (CDMOs), Clinical research organizations, Specialized laboratory equipment providers

CustomersKyorin Pharmaceutical Co., Ltd., Specialty pharmacies, Hospitals and clinics

CountryUnited States of America

Listed2015

Employees59.0

CEOSanjay S. Shukla

SectorHealthcare

IndustryBiotechnology

Websiteatyrpharma.com

FilingsSEC EDGAR

FAQ

What is aTyr Pharma's market cap?: aTyr Pharma (ATYR) has a market capitalization of $51.9M and trades on NASDAQ.
Who are aTyr Pharma's competitors?: aTyr Pharma's key competitors include Bristol Myers Squibb Company, Merck & Co., United Therapeutics, and others. These companies compete in similar markets and product categories.
Who does aTyr Pharma partner with?: aTyr Pharma's notable partners include Kyorin Pharmaceutical Co., Ltd., The Ohio State University.
What subsidiaries does aTyr Pharma have?: aTyr Pharma's subsidiaries include Pangu BioPharma.
Where is aTyr Pharma headquartered?: aTyr Pharma is headquartered in United States of America and employs approximately 59 people. It has been publicly traded since 2015.